Patent details

300943 Product Name: Ertugliflozine, desgewenst in kristalvorm, met name als co-kristal met L-pyroglutaminezuur, met name Ertugliflozin L-pyroglutamine zuur

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300943
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2334687
Status:
SPC granted but not yet in force
Application number:
300943
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1267
Marketing Authorization Type:
EEA
Marketing Authorization Date:
23/03/2018
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
27/06/2018
First Marketing Authorization date:
23/03/2018
Grant date:
07/08/2018
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
05/07/2018
SPC/SPC Extension Expiration Date:
22/03/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
16/06/2023
 
 

 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)

Historical Applicant/holder

From:
27/06/2018
To:
16/06/2023

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
27/06/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
33/18
Publication date:
08/08/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
29/18
Publication date:
11/07/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202301234A
Date Registered:
16/06/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/08/2029
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
07/08/2018 SPC Documents Certificate SPC 1 PDF /4/4/9/7/8/0800287944/docs/300943_5_supplprotectioncertificate20180810103726447.pdf
07/08/2018 Outgoing Correspondence Decision grant 1 PDF /4/4/9/7/8/0800287944/docs/300943_6_outgoingcorrespondence20180810103703884.pdf
10/07/2018 Outgoing Correspondence Confirmation receipt request 1 PDF /4/4/9/7/8/0800287944/docs/300943_1_216953l174.pdf
27/06/2018 SPC Documents SPC Documents 19 PDF /4/4/9/7/8/0800287944/docs/300943_0_supplprotectioncertificate20180705012031440.pdf
27/06/2018 Application Form First filed application form 2 PDF /4/4/9/7/8/0800287944/docs/300943_2_applicationform20180705012031184.pdf
27/06/2018 SPC Documents Marketing Authorization SPC 4 PDF /4/4/9/7/8/0800287944/docs/300943_3_supplprotectioncertificate20210119115011453.pdf
27/06/2018 SPC Documents Annex SPC 2 PDF /4/4/9/7/8/0800287944/docs/300943_4_supplprotectioncertificate20210119115011349.pdf